Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Neogen Chemicals Earnings Call: Key Takeaways

Neogen delivered volume-led Q4 growth but faces significant execution hurdles as battery project costs ballooned by ₹250cr+ while timelines shifted to the right.

Why this was an Alfa AlertNot a filter event. Results and FY27 standalone guidance are largely in line with previous expectations.
Highlights
Revenue growth22% YoY Q4 growth, primarily driven by strong volumes.
MarginsEBITDA margin maintained at 17.8% despite supply chain disruptions.
Demand visibilityStrong demand visibility for lithium salts and electrolyte formulations.
Management confidenceBalanced tone despite significant capex revisions and timeline delays.

Growth

FY26 revenue grew 11% volume-led; Inorganic chemicals segment surged 145% on demand for lithium compounds.

Outlook

FY27 standalone revenue guided at ₹875-950cr; combined FY29 revenue potential of ₹3700-4200cr.

Risks

Battery capex revised upwards from ₹1500cr to ₹1800cr; persistent project delays risk liquidity strain.

Source

Earnings Call filed with BSE, NSE: NEOGEN. Summary written with AI assistance from the document.

Read the document ↗

Neogen Chemicals Ltd: key numbers

Share price
₹2,385.20
Market cap
₹7,166 Cr
Revenue (annual)
₹862.0 Cr
Net profit (annual)
₹28.75 Cr
P/E (TTM)
201.5×Sector 37.5×
Promoter holding
48.31%-2.92% QoQ
FII holding
4.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Neogen Chemicals Ltd

All →
19:49 IST BSE
Capital Structure Change

Neogen Chemicals Capital Structure Change

Neogen Chemicals' subsidiary, Neogen Morita New Materials Limited, approved a preferential issue of 7,20,000 equity shares worth ₹76.80 Crore to Morita Investment Limited.

Value
₹76.80 Cr
19:12 IST BSE
Credit Rating

Neogen Chemicals Credit Rating

CRISIL Ratings reaffirmed and revised outlooks for Neogen Chemicals and subsidiary Neogen Ionics' facilities and debt, citing improved financial risk profile and completed QIP funding.

18:19 IST BSE
Debt & Borrowing

Neogen Chemicals Debt & Borrowing: ₹1.63 Cr

Neogen Chemicals has paid the interest on its listed non-convertible debentures for September 2026, totaling ₹1.63 Crore.

Value
₹1.63 Cr
16:53 IST BSE
Other Announcement

Neogen Chemicals Other Announcement

Neogen Chemicals Ltd has submitted its quarterly shareholding pattern disclosure as per SEBI regulations. This routine filing details the current equity distribution among promoters and public shareholders.

00:33 IST BSE
Capital Structure Change

Neogen Chemicals Capital Structure Change

Neogen Chemicals Limited allotted equity shares via a Qualified Institutional Placement (QIP). The allotment increases the total paid-up share capital of the company.

00:33 IST BSE
Fund Raise

Neogen Chemicals Fund Raise of ₹600 Cr

Neogen Chemicals is raising funds via a Qualified Institutional Placement of 26.61 lakh equity shares. This issuance is valued at approximately ₹600 Crore.

Value
₹600.0 Cr